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To evaluate the role of genetic polymorphisms of NAD(P)H:quinone 
oxidoreductase 1 (NQO1) related to the carcinogen metabolism and 
oxidative status, genotypes of two NQO1 polymorphisms IVS1-27C>G 
and Ex6+40C>T were determined in 616 lung cancer cases and 616 
lung cancer-free controls. When the effect of each NQO1 allele and 
diplotype composed of two NQO1 SNP sites on lung cancer risk was 
evaluated, any NQO1 genotype or diplotype did not show the associa-
tion with lung cancer risk. However, in the analyses of the combined 
effects of smoking and NQO1 diplotype, smokers with other than 
CT/CT diplotype showed signiﬁcantly increased risk of lung cancer 
compared with nonsmoker with other than CT/CT diplotype (adjusted 
OR=2.2, 95% CI, 1.67-3.02) and smokers with CT/CT diplotype 
showed the highest OR of lung cancer (adjusted OR=2.7, 95% CI, 
1.78-4.21). Trend test showed an additive interaction between smok-
ing and NQO1 diplotype (Ptrend<0.01). In the subgroup analyses, the 
additive effect between smoking and NQO1 diplotype was found to be 
more apparent in squamous cell carcinoma although this effect was sta-
tistically signiﬁcant in all lung cancer cell types (NSCLC, Ptrend<0.01; 
AC, Ptrend=0.02; SCC, Ptrend<0.01; other NSCLCs, Ptrend<0.01; and 
SCLC, Ptrend<0.01). This result suggests that haplotypes of NQO1 
gene play an important role in the development of lung cancer by 
producing an additive interaction between smoking and NQO1 gene for 
lung cancer risk.
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Background: Lung cancer is the leading cause of cancer death in the 
United States and Western Europe. Adenocarcinoma, the histological 
subtype most frequently seen in never smokers and former smokers, is 
now the most common type of lung cancer in men and women in the 
United States. The increasing incidence of lung adenocarcinoma and its 
lethal nature underline the importance of understanding the develop-
ment and progression of this disease, and the need for the development 
of accurate tools for early diagnosis. Atypical adenomatous hyperplasia 
(AAH) and bronchioalveolar carcinoma (BAC), deﬁned as non-in-
vasive lesions, are thought to be sequential precursors along the path 
of progression to lung adenocarcinoma. Elucidation of the molecular 
changes underlying the development and progression of lung adenocar-
cinoma is of great importance for devising targeted drugs and methods 
of early detection. DNA hypermethylation at promoter CpG islands is 
now recognized as a key mechanism for tumor suppressor gene inacti-
vation in cancer. Identiﬁcation of abnormal methylation changes could 
provide important insights into the mechanism of cancer development, 
and in addition could yield powerful biomarkers for cancer. 
Methods: Here we use MethyLight®, a sensitive, quantitatively ac-
curate, automated DNA methylation analysis technique to examine 
DNA methylation levels at loci that we have previously shown to be 
highly signiﬁcantly hypermethylated in lung adenocarcinoma compared 
to adjacent non-tumor tissue from the same patient. We examine the 
methylation levels in a unique collection of normal adjacent lung, pre-
invasive lesions (AAH and BAC), mixed adenocarcinoma samples with 
a BAC component, and adenocarcinoma, representing adenocarcinoma 
in its different developmental stages. 
Results: We observe differences in methylation levels for the different 
loci examined, with some loci (such as CDKN2A) showing hypermeth-
ylation already in adjacent non-tumor lung, others (such as SFRP1) 
showing no methylation in normal lung but methylation in AAH and 
BAC/adenocarcinoma, and yet others (such as SFRP5) showing only 
methylation in adenocarcinoma. 
Conclusions: The occurrence of methylation of different loci in distinct 
subsets (normal lung, AAH, BAC, adenocarcinoma) suggests that indi-
vidual loci might be methylated in a temporally distinct fashion during 
developing lung adenocarcinoma. The identiﬁcation of sequential 
epigenetic alterations during progression to lung adenocarcinoma will 
broaden our molecular understanding of the disease, providing insights 
that may be applicable to the development of targeted drugs. Equally 
important, such DNA methylation changes will be powerful markers 
for early detection and patient classiﬁcation. 
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Background: Small cell and non small cell lung carcinomas exhibit a 
series of chromosomal abnormalities. However, few reports exist con-
cerning the chromosomal alterations of normal bronchial mucosa cells 
of smokers. In the current study, we examined the possible relationship 
of smoking and 3p and other numerical chromosome aberrations of 
normal mucosal cells. 
Methods: Brush cytology samples of 25 patients were available for 
this study, where bronchoscopy was performed for clinical symptoms 
of haemoptysis, dyspnoea, pulmonary inﬁltration etc., but lung cancer 
was not found. Cytological smears were prepared and one H&E stained 
smear was used for cytological examination to rule out dysplasia, 
whereas dual color ﬂuorescent in situ hybridization (FISH) was per-
formed on the others. A mixture of chromosome 3 centromeric probe 
(red) and telomeric 3p probe (green) were used to detect the possible 3p 
deletion or other numerical chromosome alterations.
Results: 10 patients were non-smoker, 9 patients were smoker and 6 
patients were ex-smoker. The ex-smokers had given up smoking 5-31 
years (mean: 8,1 years) before our examination. 4 of 10 smoker patients 
and 3 of 6 ex-smoker patients had signiﬁcantly higher 3p chromosome 
or other numerical aberrations (deletion, monosomy, trisomy) com-
pared to the healthy control (non-smoker) patients. Average percentage 
of chromosomal alteration in non smoker patients was 2.7%. 
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We conclude based on these preliminary results:
1. The frequency of chromosomal alteration in morphologically normal 
cells among smoker and ex-smoker patient is similar. 
2. The risk for chromosomal instability in morphologically normal 
cells of smoker and ex-smoker patients is higher than in those who 
has never smoked. 
3. Chromosomal instability seems to be still stable after 8 years re-
fraining smoking.
4. About half of the smoker and ex smoker patients have detectable 
increased chromosomal alteration in their morphologically normal 
bronchial mucosa cells compared to the healthy population.
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Background: It is known that chromium is an inhaled carcinogen and 
an important risk factor in the development of lung carcinoma. In 11th 
World Conference on Lung Cancer, we measured the accumulation of 
chromium in 90 biopsy specimens (dysplasia, squamous metaplasia, 
goblet cell hyperplasia, basal cell hyperplasia and normal bronchial epi-
thelia) from chromate workers using a microscopic X-ray ﬂuorescence 
analyzer with transmitted X-ray mapping imaging, and demonstrated 
that the amount of chromium accumulation signiﬁcantly increased 
according to the progression of malignant change of the bronchial 
epithelium (p=0.003). On the other hand, our previous studies have 
revealed that the frequency of replication error (RER) in chromate lung 
cancer is very high and that the inactivation of DNA mismatch repair 
gene hMLH1 expression strongly correlated with the microsatellite 
high instability phenotype. We speculate the carcinogenesis process of 
chromate lung cancer: the repression of hMLH1 protein→the genetic 
instability→the abnormality of cancer-related genes. In this study, we 
examined the expression of hMLH protein in pre-malignant lesions 
of the bronchial biopsy specimens from chromate workers, and the 
relationship between the expression of hMLH protein and the amount 
of chromium accumulation. 
Material and Methods: To detect lung carcinoma at an early stage, We 
performed biopsies of the bronchus for 83 chromate industry workers 
in Tokushima, Japan, in 1982. Dysplasia was recorded in 3 specimens, 
squamous metaplasia in 14 specimens, goblet cell hyperplasia in 12 
specimens, basal cell hyperplasia in 13 specimens, hypertrophy of 
basement membrane in 14 specimens, and normal epithelia in 27 speci-
mens.We examined the expression of hMLH protein in the bronchi of 2 
dysplasia, 7 squamous metaplasia, 2 goblet cell hyperplasia and 4 basal 
cell hyperplasia specimens.Immunohistochemical staining for hMLH1 
in formalin-ﬁxed, parafﬁn-embedded tissue sections was performed 
using the Catalyzed Signal Ampliﬁcation system (DAKO Co., Carpin-
teria, CA) method. Mouse monoclonal antibodies to hMLH1 (clone G 
168-728, BD Biosciences Pharmingen, San Diego, CA) were applied, 
diluted 1:300, and tissue sections were incubated 2 overnight at 4 
degrees. Under microscopy, we evaluated at least 200 tumor cells per 
high power ﬁeld, which were more stained in all ﬁelds. The frequency 
of nuclear staining was scored as none (0%), scant (<35%), moderate 
(≥35%,≤70%), and diffuse (>70%).
Results: There were 7 cases in scant group, 4 cases in moderate group 
and 4 cases in diffuse group. We classiﬁed scant group as “repression” 
of hMLH protein. The repression rate was 100% in dysplasia (2 cases), 
57% (4 cases) in squamous metaplasia, 25% (1 case) in basal cell 
hyperplasia and 0% in goblet cell hyperplasia. There was a difference 
of hMLH expression between dysplasia+metaplasia and hyperplasia 
(Fisher, p=0.084). The amount of chromate accumulation of “repres-
sion” and “non-repression” groups was 5.98±8.52 and 8.92±9.14, 
respectively (p=0.55). 
Conclusion: There was a difference of hMLH expression between 
dysplasia+metaplasia and hyperplasia. It is well known that dysplasia 
and squamous metaplasia lesions are pre-malignant lesion, but hyper-
plasia is not. We speculate that dysfunction of DNA mismatch repair 
hMLH involve early stage of carcinogenesis of chromate lung cancer.
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Background: The incidence of lung cancer has been rapidly increasing 
in the world and it has been the most frequent malignancy. The most 
signiﬁcant carcinogenesis of lung cancer has been smoking. Recently, 
proportion of adenocarcinoma has been increasing. Asian women 
adenocarcinoma lung cancer patients show frequently EGFR mutation. 
These patients show high sensitivity to geﬁtinib. A considerable propor-
tion of no smoker women have lung cancer, which is a serious problem. 
We tried to ﬁnd novel cancer related genes which are different from 
smoker lung cancer patients.
Methods: We will perform array comparative genomic hybridiza-
tion (CGH) with 1,440 human bacterial artiﬁcial chromosome (BAC) 
clones to assess copy number changes in 20 lung cancer samples. These 
patients received operation in our hospital. Array-CGH methods have 
been used for genome-wide, high-resolution analysis of chromosomal 
alterations. All of the patients included had received operation in our 
hospital. 10 patients are no smoker (No smoker group) and 10 patients 
were smoker (Smoker group).
Results: Potential prognostic variables were comparable between the 
two groups. In an unsupervised clustering analysis, samples from each 
group were well separated. The average frequency of copy number 
changes was similar between the two groups. 
Conclusion: Our array CGH analysis with BAC clones could detect 
various genomic alterations
in no smoker lung cancers, and no smoker lung cancer samples showed 
a different pattern of DNA copy number changes than did smoker 
lung cancer group samples. We have ﬁnished 8 no smoker lung cancer 
samples and 3 smoker lung cancer samples. We will show the array-
CGH data about difference between smoker patient pattern and no-
smoker. Especially genetic characteritics of adenocarcinoma in women 
no-smoker patients will be shown.
